Health ❯ Medicine ❯ Pharmacology

Diabetes

Metformin Semaglutide GLP-1 Receptor Agonists GLP-1 Medications Type 2 Diabetes GLP-1 Agonists Side Effects PCOS Long-term Management Tirzepatide

Study Finds Small Rise in Smell and Taste Diagnoses Among People on GLP‑1 Diabetes Drugs

Prospective studies are needed to test whether the drugs directly affect chemosensory nerves.

Metformin’s Glucose-Lowering Power Traced to the Gut, Not the Liver

Common Gene Variants May Blunt GLP-1 Diabetes Drugs for 1 in 10 People

Metformin Lowers Blood Sugar Through Brain Circuit, Mouse Study Finds

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Early Metformin Use Tied to Lower Long COVID Risk, New Commentary Finds

Metformin Linked to 37% Lower Odds of Intermediate Macular Degeneration in Diabetic Patients

Metformin Blunts Exercise Benefits in Rutgers Randomized Trial

Metformin Use Tied to Lower Copper and Iron, Higher Zinc in Human Study

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

Metformin Requires Hypothalamic Rap1 Inactivation to Lower Blood Sugar

GLP-1 Weight-Loss Injections Show Hormonal and Neuroprotective Benefits

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds

Diabetes Drug Metformin Shows Promise in Slowing Brain Aging